|
Natural compounds in the treatment of nonalcoholic fatty liver disease: A review study
|
Koroush Ghanadi   , Mehdi Mohammadian Amiri , Aliasghar Manouchehri , Mohammad Darvishi * , Neda Dastyar , Mahdeyeh Ahmadi , Saber Abbaszadeh |
|
|
| Keywords: Liver, Chronic disease, Antioxidants, Medicinal plants |
|
|
Full-Text [PDF 122 kb]
| Abstract (HTML) (2338 Views)
|
Memorial article: Review Article |
Subject:
Special
Received: 2022/12/17 | Accepted: 2023/04/25
|
|
|
|
|
|
|
Full-Text: (19 Views) |
References
1. Yang JM, Sun Y, Wang M, Zhang XL, Zhang SJ, Gao YS, et al. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease. World Journal of Gastroenterology. 2019 Sep 9;25(34):5105.
2. Vespasiani-Gentilucci U, Gallo P, Dell’Unto C, Volpentesta M, Antonelli-Incalzi R, Picardi A. Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables. World Journal of Gastroenterology. 2018 Nov 11;24(43):4835.
3. Guo Y, Li JX, Mao TY, Zhao WH, Liu LJ, Wang YL. Targeting Sirt1 in a rat model of high-fat diet-induced non-alcoholic fatty liver disease: Comparison of Gegen Qinlian decoction and resveratrol. Experimental and Therapeutic Medicine. 2017 Nov 1;14(5):4279-87.
4. Mitra S, De A, Chowdhury A. Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Translational Gastroenterology and Hepatology. 2020;5(2): 1.
5. Stefan N, Häring HU, Cusi K. Non-alcoholic fatty liver disease: Causes, diagnosis, cardiometabolic consequences, and treatment strategies. The Lancet Diabetes & Endocrinology. 2019 Apr 1;7(4):313-24.
6. Yan T, Yan N, Wang P, Xia Y, Hao H, Wang G, et al. Herbal drug discovery for the treatment of nonalcoholic fatty liver disease. Acta Pharmaceutica Sinica B. 2020 Jan 1;10(1):3-18.
7. Wong VW, Wong GL, Chan RS, Shu SS, Cheung BH, Li LS, et al. Beneficial effects of lifestyle intervention in nonobese patients with non-alcoholic fatty liver disease. Journal of Hepatology. 2018 Dec 1;69(6):1349-56.
8. Xu J, Wang R, You S, Zhang L, Zheng P, Ji G, et al. Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial. Trials. 2020 Dec;21:1-9.
9. Cheng C, Zhuo S, Zhang B, Zhao X, Liu Y, Liao C, et al. Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer. International Journal of Biological Sciences. 2019;15(8):1654.
10. Li S, Xu Y, Guo W, Chen F, Zhang C, Tan HY, et al. The impacts of herbal medicines and natural products on regulating the hepatic lipid metabolism. Frontiers in Pharmacology. 2020 Mar 24;11:351.
11. Li Y, Zhao J, Zheng H, Zhong X, Zhou J, Hong Z. Treatment of nonalcoholic fatty liver disease with total alkaloids in Rubus aleaefolius Poir through regulation of fat metabolism. Evidence-Based Complementary and Alternative Medicine. 2014 Jan 1;2014.
12. Alaynick WA. Nuclear receptors, mitochondria and lipid metabolism. Mitochondrion. 2008 Sep 1;8(4):329-37.
13. Zhu X, Bian H, Wang L, Sun X, Xu X, Yan H, et al. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway. Free Radical Biology and Medicine. 2019 Sep 1;141:192-204.
14. Manwani B, McCullough LD. Function of the master energy regulator adenosine monophosphate-activated protein kinase in stroke. Journal of Neuroscience Research. 2013 Aug;91(8):1018-29.
15. Yao H, Qiao YJ, Zhao YL, Tao XF, Xu LN, Yin LH, et al. Herbal medicines and nonalcoholic fatty liver disease. World Journal of Gastroenterology. 2016 Aug 8;22(30):6890.
16. Shum M, Ngo J, Shirihai OS, Liesa M. Mitochondrial oxidative function in NAFLD: Friend or foe?. Molecular Metabolism. 2021 Aug 1;50:101134.
17. Choi E, Jang E, Lee JH. Pharmacological activities of Alisma orientale against nonalcoholic fatty liver disease and metabolic syndrome: Literature review. Evidence-Based Complementary and Alternative Medicine. 2019 Oct;2019. 2943162.
Vastrad BM, Vastrad CM. Identification of hub genes and key pathways in pediatric Crohn's disease using next generation sequencing and bioinformatics analysis. bioRxiv. 2022:2022-07.
19. Xiao J, Guo R, Fung ML, Liong EC, Chang RC, Ching YP, et al. Garlic-derived S-allylmercaptocysteine ameliorates nonalcoholic fatty liver disease in a rat model through inhibition of apoptosis and enhancing autophagy. Evidence-Based Complementary and Alternative Medicine. 2013 Oct;2013.
20. Vasarri M, Barletta E, Degl’Innocenti D. Posidonia oceanica (L.) delile extract reduces lipid accumulation through autophagy activation in hepg2 cells. Pharmaceuticals. 2021 Sep 24;14(10):969.
21. Zheng X, Zhang XG, Liu Y, Zhu LP, Liang XS, Jiang H, et al. Arjunolic acid from Cyclocarya paliurus ameliorates nonalcoholic fatty liver disease in mice via activating Sirt1/AMPK, triggering autophagy and improving gut barrier function. Journal of Functional Foods. 2021 Nov 1;86:104686.
22. Leung C, Rivera L, Furness JB, Angus PW. The role of the gut microbiota in NAFLD. Nature reviews Gastroenterology & Hepatology. 2016 Jul;13(7):412-25.
23. Mouzaki M, Comelli EM, Arendt BM, Bonengel J, Fung SK, Fischer SE, et al. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology. 2013 Jul;58(1):120-7.
24. Porras D, Nistal E, Martinez-Florez S, Pisonero-Vaquero S, Olcoz JL, Jover R, et al. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Free Radical Biology and Medicine. 2017 Jan 1;102:188-202.
25. Farzanegi P, Dana A, Ebrahimpoor Z, Asadi M, Azarbayjani MA. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation. European Journal of Sport Science. 2019 Aug 9;19(7):994-1003.
26. Cheng F, Ma C, Wang X, Zhai C, Wang G, Xu X, et al. Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: A rat study. BMC Complementary and Alternative Medicine. 2017 Dec;17:1-10.
27. Shi KQ, Fan YC, Liu WY, Li LF, Chen YP, Zheng MH. Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: A systematic review and meta-analysis. Molecular Biology Reports. 2012 Oct;39:9715-22.
28. Gottlieb A, Canbay A. Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression. Cells. 2019 Oct 30;8(11):1358.
29. Ji X, Shi S, Liu B, Shan M, Tang D, Zhang W, et al. Bioactive compounds from herbal medicines to manage dyslipidemia. Biomedicine & Pharmacotherapy. 2019 Oct 1;118:109338.
30. Vasala PA. Ginger, in Handbook of herbs and spices. Elsevier, Woodhead Publishing; 2012 Jan 1:319-335.
31. Arrese M, Cabrera D, Kalergis AM, Feldstein AE. Innate immunity and inflammation in NAFLD/NASH. Digestive Diseases and Sciences. 2016 May;61:1294-303.
32. Liu M-T, Huang Y-J, Zhang T-Y, Tan L-B, Lu X-F, Qin J. Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis via gut microbiota. World Journal of Gastroenterology. 2019;25(27):3590.
33. Vargas-Mendoza N, Madrigal-Santillan E, Morales-Gonzalez A, Esquivel-Soto J, Esquivel-Chirino C, y GonzalezRubio MG, et al. Hepatoprotective effect of silymarin. World Journal of Hepatology. 2014 Mar 3;6(3):144.
34. Hewlings SJ, Kalman DS. Curcumin: A review of its effects on human health. Foods. 2017 Oct 22;6(10):92.
35. Lestari ML, Indrayanto G. Curcumin, in Profiles of drug substances, excipients and related methodology. Elsevier; 2014 Jan 1;39:113-204.
36. Gruenwald J, Freder J, Armbruester N. Cinnamon and health. Critical Reviews in Food Science and Nutrition. 2010 Sep 30;50(9):822-34.
37. Charles DJ. Antioxidant properties of spices, herbs and other sources. Springer Science & Business Media; 2012 Nov 27; 231-43.
38. Bode AM, Dong Z. The amazing and mighty ginger. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd ed. 2011.
39. Gillessen A, Schmidt HH. Silymarin as supportive treatment in liver diseases: A narrative review. Advances in Therapy. 2020 Apr;37(4):1279-301.
40. Berman AY, Motechin RA, Wiesenfeld MY, Holz MK. The therapeutic potential of resveratrol: A review of clinical trials. NPJ Precision Oncology. 2017 Sep 25;1(1):1-9.
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
Ghanadi K, Mohammadian Amiri M, Manouchehri A, Darvishi M, Dastyar N, Ahmadi M et al . Natural compounds in the treatment of nonalcoholic fatty liver disease: A review study. jiitm 2023; 14 (1) :1-10 URL: http://jiitm.ir/article-1-1564-en.html
|
